Results 211 to 220 of about 6,859 (228)
Some of the next articles are maybe not open access.
Nusinersen: First Global Approval
Drugs, 2017Spinal muscular atrophy (SMA) is a rare autosomal recessive disorder characterized by muscle atrophy and weakness resulting from motor neuron degeneration in the spinal cord and brainstem. It is most commonly caused by insufficient levels of survival motor neuron (SMN) protein (which is critical for motor neuron maintenance) secondary to deletions or ...
openaire +2 more sources
Nusinersen: A Treatment for Spinal Muscular Atrophy
Annals of Pharmacotherapy, 2018Objective: To review the efficacy and safety of nusinersen (Spinraza) in the treatment of spinal muscular atrophy (SMA). Data Sources: An English-language literature search of PubMed and MEDLINE (1946 to June 2018) was performed using the terms nusinersen, ISIS-SMN (Rx), and spinal muscular atrophy.
Melanie K, Claborn +3 more
openaire +2 more sources